Health
Study shows 90.7% efficacy for the BNT162b2 COVID vaccine in 5-11 year-olds – News-Medical.Net – Burnie Online News
A new study evaluates the safety, immunogenicity, and efficacy of the BNT162b2 in children who were 5 to 11 years of age.
A new study evaluates the safety, immunogenicity, and efficacy of the BNT162b2 in children who were 5 to 11 years of age.
Continue Reading
-
Noosa News15 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Business16 hours agoSolid superannuation gains continue to roll in
-
Noosa News13 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor
-
Noosa News15 hours agoBoy charged over E-Bike crash